<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04982263</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-07-34</org_study_id>
    <nct_id>NCT04982263</nct_id>
  </id_info>
  <brief_title>Blood Coagulation Abnormalities in COVID-19 (Corona Virus Disease-19) Patients</brief_title>
  <official_title>Blood Coagulation Abnormalities in COVID-19 Patients and Correlation With Severity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The role of the coagulation parameters in predicting the severity of COVID-19 disease will be&#xD;
      assessed&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In COVID-19 patients the coagulation parameters Prothrombin concentration (PC), Activated&#xD;
      Partial Thromboplastin Time (aPTT), D Dimer, Antithrombin III (ATIII) and Fibrinogen are&#xD;
      measured and correlation with disease severity is to be investigated&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Actual">May 31, 2021</completion_date>
  <primary_completion_date type="Actual">May 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>correlation of disease severity with results of laboratory test</measure>
    <time_frame>Baseline results of coagulation profile and baseline disease severity assessment</time_frame>
    <description>The results of blood coagulation profile will be correlated with degree of severity of illness</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Agreement of abnormalities in coagulation profile with measured inflammatory markers</measure>
    <time_frame>baseline measurement of inflammatory markers</time_frame>
    <description>The inflammatory markers will be measured and correlation with abnormalities in coagulation profile will be assessed</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">125</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Mild cases</arm_group_label>
    <description>Patients with confirmed COVID-19 and with mild disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe cases</arm_group_label>
    <description>Patients with confirmed COVID-19 and with severe disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood coagulation profile</intervention_name>
    <description>Venous blood sample for measurement of blood coagulation profile</description>
    <arm_group_label>Mild cases</arm_group_label>
    <arm_group_label>Severe cases</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cases with confirmed COVID 19 disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        ● Confirmed cases with COVID 19&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        ● Known history of blood coagulopathy disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hend mohamed A Esmaeel, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sohag Univesity</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sohag University</name>
      <address>
        <city>Sohag</city>
        <zip>82425</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sohag University</name>
      <address>
        <city>Sohag</city>
        <zip>82524</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Fauci AS, Lane HC, Redfield RR. Covid-19 - Navigating the Uncharted. N Engl J Med. 2020 Mar 26;382(13):1268-1269. doi: 10.1056/NEJMe2002387. Epub 2020 Feb 28.</citation>
    <PMID>32109011</PMID>
  </reference>
  <reference>
    <citation>Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.</citation>
    <PMID>32073213</PMID>
  </reference>
  <reference>
    <citation>Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA. Hematological findings and complications of COVID-19. Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23.</citation>
    <PMID>32282949</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 26, 2021</study_first_submitted>
  <study_first_submitted_qc>July 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2021</study_first_posted>
  <last_update_submitted>July 27, 2021</last_update_submitted>
  <last_update_submitted_qc>July 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Hend Mohammed Abdelraheem Esmaeel</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

